Back
SMN1HGNC Autosomal recessivePubMed

Characterisation of the SMN1/SMN2 locus using a highly specific variant caller on whole-genome sequence data from 500,000 individuals.

Hall TS, Beaumont RN, Fasham J, et al.Eur J Hum Genet 2026 · July 2026
Relevance score
9/10
Disease / domain
Spinal muscular atrophy (SMA)
Source
PubMed
PMID 42393335
Share on LinkedIn

Variant / mechanism

SMN1 copy-number and deletion calling from short-read WGS via a dedicated caller (SMNCopyNumberCaller), overcoming high homology with the SMN2 paralog

Summary

Spinal muscular atrophy (SMA) is caused by bi-allelic loss of SMN1; ~95% of infantile cases result from homozygous exon 7-8 deletions that are hard to detect with short reads due to high similarity with the SMN2 paralog. The authors evaluate a dedicated caller (SMNCopyNumberCaller) on WGS from ~490,000 UK Biobank adults. Performance is excellent: 8,856 heterozygous carriers (1.8%) and only 2 individuals (0.0004%) with homozygous SMN1 deletions, one of whom had diagnosed SMA. A PheWAS confirms accuracy through associations with circulating proteins encoded or regulated at the locus.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

Addresses a well-known technical bottleneck — short-read detection of SMN1 hampered by the SMN2 paralog. With SMA newborn screening and presymptomatic therapies now established, the value is direct: leveraging existing WGS data for carrier screening and diagnosis without a dedicated assay.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 3/3Evidence 3/3Novelty 1/2Sample 1/1Publication 1/1

Clinical impact: 3/3 · Evidence strength: 3/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 9/10

Keywords

SMN1spinal muscular atrophynewborn screeningWGSvariant callerUK Biobank
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime